From mboxrd@z Thu Jan 1 00:00:00 1970 Received: from troikaapharmaceuticals.cloudhostdns.net (unknown [198.38.84.68]) (using TLSv1.2 with cipher ECDHE-RSA-AES128-GCM-SHA256 (128/128 bits)) (No client certificate requested) by smtp.subspace.kernel.org (Postfix) with ESMTPS id BC8A2347BD9 for ; Fri, 28 Aug 2026 02:53:29 +0000 (UTC) Authentication-Results: smtp.subspace.kernel.org; arc=none smtp.client-ip=198.38.84.68 ARC-Seal:i=1; a=rsa-sha256; d=subspace.kernel.org; s=arc-20240116; t=1787885613; cv=none; b=g+l00khcLIGfungyb5q2ZXsRX3i8mR2Cdf05hH7UlNbzX5WYbGaFB0yDKNkW9YuRVLlHajdyhdDQ9ucg+bOa6/E8M93w5py9bkE3Og4tAEvaL4XL1D45IMXrN8QyhddAZAgYb0+AMBiMfMiRCO9XZjZdRUuGGHclUFFw3o8Z8JA= ARC-Message-Signature:i=1; a=rsa-sha256; d=subspace.kernel.org; s=arc-20240116; t=1787885613; c=relaxed/simple; bh=SDUXu+lk+EqcloBSXYdzXQS6i7btCwo1oT1VX4l0SpE=; h=From:To:Subject:Date:Message-ID:MIME-Version:Content-Type; b=CAv7Bp0nIEvEGKon7hhvacrHPjTxLW/g6GCjP11BMi/cgxsUdGKO9FwVdkuPIu1rRs9RhrGBD5nPdlDaaIZqrZkGGuqwVhWRNoCl6BCMJUcOFz0nMOyq/HkCefLLLo9fgoZHsrajOPAGWyknWK+Y6XtUuMoTz0GInRAx6VqETCM= ARC-Authentication-Results:i=1; smtp.subspace.kernel.org; dmarc=pass (p=none dis=none) header.from=troikaanutrasciences.com; spf=pass smtp.mailfrom=troikaanutrasciences.com; dkim=pass (1024-bit key) header.d=troikaanutrasciences.com header.i=@troikaanutrasciences.com header.b=F3uykLhE; arc=none smtp.client-ip=198.38.84.68 Authentication-Results: smtp.subspace.kernel.org; dmarc=pass (p=none dis=none) header.from=troikaanutrasciences.com Authentication-Results: smtp.subspace.kernel.org; spf=pass smtp.mailfrom=troikaanutrasciences.com Authentication-Results: smtp.subspace.kernel.org; dkim=pass (1024-bit key) header.d=troikaanutrasciences.com header.i=@troikaanutrasciences.com header.b="F3uykLhE" Received: from [85.215.140.87] (unknown [216.73.162.116]) by troikaapharmaceuticals.cloudhostdns.net (Postfix) with ESMTPSA id 441FCA551C for ; Fri, 28 Aug 2026 08:17:58 +0530 (IST) DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=troikaanutrasciences.com; s=default; t=1787885280; bh=SDUXu+lk+EqcloBSXYdzXQS6i7btCwo1oT1VX4l0SpE=; h=From:To:Subject; b=F3uykLhEzE8cRFUcL8hUpBuTYShpd1qeTWOOD5Qx2v89ZTyckhcWYmYzIe/UV5vvl xBZ1wKciNfNqpU9bzsFZ/n7RWh6GjKySScE2bSBr8XjrWkyhHnsl/FNpVDUDn4yWgt KNHtTvaUhOkroAUi7MS3C5JllC7hxMCqjjUMQ6gU= Authentication-Results: troikaapharmaceuticals.cloudhostdns.net; spf=pass (sender IP is 216.73.162.116) smtp.mailfrom=nutra@troikaanutrasciences.com smtp.helo=[85.215.140.87] Received-SPF: pass (troikaapharmaceuticals.cloudhostdns.net: connection is authenticated) Reply-To: yusinsdoo@financier.com From: Yusin Writes To: git@vger.kernel.org Subject: Exclusive Strategic Investment Opportunity Date: 27 Aug 2026 20:48:13 -0600 Message-ID: <20260827204804.582BE7C4E4E69B37@troikaanutrasciences.com> Precedence: bulk X-Mailing-List: git@vger.kernel.org List-Id: List-Subscribe: List-Unsubscribe: MIME-Version: 1.0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Hello, I am a Fund Manager at Fidelity Investment International,=20 overseeing over USD 1.2 trillion in client capital. Through my role, I have generated substantial returns from an=20 annual 1.2% excess profit on investor funds. I am now seeking a=20 trusted partner to act as a nominal investor to receive these=20 proceeds from Fidelity=E2=80=99s Marginal Capital Fund. All necessary procedures and documentation have been arranged to=20 ensure a smooth transaction through our clearing houses. I look forward to your response. Yours sincerely, Yusin